Colossal Biosciences

Colossal Biosciences is a biotech company that focuses on gene editing to develop potential cures for various diseases. Their research is centered around new gene-editing technologies and they aim to improve upon current methods of gene therapy, including CRISPR. With a team of experienced scientists, Colossal Biosciences aims to revolutionize the way we treat diseases such as cancer and genetic disorders.

Colossal Biosciences's People

Investor Kent Wakeford